⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRXA News
Veraxa Biotech AG Ordinary Shares
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
globenewswire.com
VRXA
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
globenewswire.com
VRXA
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
globenewswire.com
VRXA
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
globenewswire.com
VRXA
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
globenewswire.com
VRXA
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
globenewswire.com
VRXA
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
globenewswire.com
VRXA